Borwin Bandelow Selected Research

Agoraphobia

1/2012	Disorder-specific emotional imagery for differential and quantitative assessment of agoraphobia.
10/2010	A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder.
9/2006	What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
10/2004	Treatment-resistant panic disorder.
3/2004	Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Borwin Bandelow Research Topics

Disease

28	Anxiety Disorders (Anxiety Disorder) 06/2022 - 10/2002
16	Panic Disorder (Panic Attack) 01/2020 - 10/2002
9	Social Phobia 01/2018 - 10/2002
7	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 09/2006
5	Agoraphobia 01/2012 - 03/2004
4	Borderline Personality Disorder (Personality Disorders, Borderline) 11/2021 - 04/2010
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017 - 08/2003
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2017 - 10/2002
2	Hypersensitivity (Allergy) 01/2020 - 01/2017
2	Treatment-Resistant Depressive Disorder 01/2019 - 12/2018
2	Mental Disorders (Mental Disorder) 01/2012 - 09/2006
2	Sleepiness 12/2011 - 04/2010
2	Substance-Related Disorders (Drug Abuse) 04/2010 - 01/2008
1	Pathologic Processes 01/2022
1	Chronic Pain 01/2022
1	Antisocial Personality Disorder (Antisocial Personality) 11/2015
1	Neurocognitive Disorders (Clerambault Syndrome) 03/2015
1	Alcoholism (Alcohol Abuse) 01/2013
1	Sleep Deprivation 01/2013
1	Schizophrenia (Dementia Praecox) 01/2013
1	Medically Unexplained Symptoms 12/2011
1	Constipation 12/2011
1	Headache (Headaches) 04/2010
1	Nausea 04/2010
1	Dizziness (Lightheadedness) 04/2010
1	Anorexia 04/2010
1	Fatigue 04/2010
1	Parkinson Disease (Parkinson's Disease) 12/2009
1	Weight Gain 03/2004
1	Psychomotor Disorders 08/2003
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2002

Drug/Important Bio-Agent (IBA)

7	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2022 - 10/2006
7	Serotonin (5 Hydroxytryptamine)IBA 06/2022 - 10/2006
7	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2022 - 10/2002
5	Quetiapine Fumarate (Seroquel)FDA Link 02/2014 - 12/2009
5	Pharmaceutical PreparationsIBA 06/2013 - 03/2002
5	Escitalopram FDA Link 06/2009 - 09/2006
4	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2019 - 10/2002
4	Pregabalin (Lyrica)FDA Link 06/2012 - 07/2007
4	BenzodiazepinesIBA 01/2008 - 10/2002
3	EnzymesIBA 01/2022 - 01/2012
3	Opioid Analgesics (Opioids)IBA 11/2021 - 04/2010
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2015
3	Anti-Anxiety Agents (Anxiolytics)IBA 01/2012 - 07/2007
3	Paroxetine (Paxil)FDA LinkGeneric 10/2010 - 03/2004
2	Narcotic Antagonists (Opioid Antagonists)IBA 11/2021 - 04/2010
2	gamma-Aminobutyric Acid (GABA)IBA 01/2017 - 01/2012
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017 - 01/2012
2	Antidepressive Agents (Antidepressants)IBA 02/2014 - 01/2007
2	Oxidoreductases (Dehydrogenase)IBA 01/2012 - 10/2004
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 06/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	LipidsIBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	Naltrexone (ReVia)FDA LinkGeneric 11/2021
1	Carbon DioxideIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Cholecystokinin (Pancreozymin)IBA 01/2017
1	Atrial Natriuretic Factor (ANF)IBA 01/2017
1	Nerve Growth Factors (Neurotrophins)IBA 01/2017
1	NeuropeptidesIBA 01/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017
1	Nerve Growth Factor (NGF)IBA 01/2017
1	4-aminospiroperidolIBA 11/2015
1	Amyloid (Amyloid Fibrils)IBA 03/2015
1	CannabinoidsIBA 01/2013
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2012
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 05/2012
1	Psychotropic Drugs (Psychoactive Drugs)IBA 05/2012
1	Glutamic Acid (Glutamate)FDA Link 01/2012
1	glutamate decarboxylase 1IBA 01/2012
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2012
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2010
1	Substance PIBA 02/2010
1	GTP-Binding Proteins (G-Protein)IBA 11/2009
1	Prostaglandins BIBA 03/2009
1	neuropeptide Y5 receptorIBA 06/2008
1	Neuropeptide YIBA 06/2008
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 10/2004
1	Sertraline (Zoloft)FDA LinkGeneric 03/2004
1	Clomipramine (Anafranil)FDA LinkGeneric 10/2002
1	Buspirone (Buspar)FDA LinkGeneric 10/2002
1	Imipramine (Janimine)FDA LinkGeneric 10/2002
1	Moclobemide (Arima)IBA 10/2002
1	TabletsIBA 03/2002
1	N-acetyltryptophanamide (NATA)IBA 03/2002
1	Hypnotics and Sedatives (Sedatives)IBA 03/2002
1	Zolpidem (Ambien)FDA LinkGeneric 03/2002

Therapy/Procedure

9	Therapeutics 01/2019 - 03/2002
8	Drug Therapy (Chemotherapy) 01/2021 - 03/2002
2	Aftercare (After-Treatment) 01/2018 - 12/2009
1	Telescopes 01/2013
1	Secondary Prevention 11/2005